Login
$CADL
$5.85 +$0.04 (0.69%) After hours

Company Executives

Officer Age In this role Joined Source
Paul Peter Tak Also a director
Chief Executive Officer, President and Director
66 Since 2020
6 years
Not stated
Charles Schoch
Chief Financial Officer, Treasurer and Secretary
41 Not stated 2021
Francesca Barone
Chief Scientific Officer
49 Not stated 2020
W. Garrett Nichols
Chief Medical Officer
57 Not stated Not stated
Seshu Tyagarajan
Chief Technology Officer
Title from the Form 4 dated Aug 17, 2026
58 Not stated Not stated
Maria Ostrovsky
General Counsel
Title from the Form 4 dated Nov 3, 2026
Not stated Not stated Not stated
Mark E. Sims
Chief Commercial Officer
Title from the Form 4 dated Jul 6, 2026
Not stated Not stated Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 29, 2026 · updated by the 8-K of Sep 10, 2026

Directors
11
serving now
Independent
1 of 1
stated in the proxy; 10 not stated
Average tenure
5.2 years
from year joined
CEO also chairs the board
No
Paul B. Manning
Director Age On board Independent Committees Other public boards 2025 pay Source
Paul B. Manning
70 2018
8 years
Not stated
Compensation Committee
Liquidia Corporation $130,546
Paul Peter Tak, M.D., Ph.D., FMedSci
66 2020
6 years
Not stated None stated None stated Paid as CEO
Edward J. Benz, Jr.
79 2017
9 years
Not stated
Nominating and Corporate Governance Committee · Chair
None stated $103,546
Maha Radhakrishnan, M.D.
56 2025
1 year
Not stated
Audit Committee
Entrada Therapeutics, Inc. $158,346
Renee Gaeta
45 2022
4 years
Not stated None stated None stated $103,046
Gary J. Nabel, M.D., Ph.D.
72 2022
4 years
Not stated
Nominating and Corporate Governance Committee
Siga Technologies, Inc. $99,546
Joseph C. Papa, R.Ph., M.B.A.
70 2022
4 years
Not stated
Compensation Committee
Prometheus Biosciences, Inc. $101,810
Nicoletta Loggia, Ph.D., R.Ph.
58 2023
3 years
Not stated None stated None stated $107,019
Christopher Martell
47 2018
8 years
Not stated
Nominating and Corporate Governance Committee
None stated $114,546
Diem Nguyen, Ph.D.
54 2021
5 years
Not stated
Compensation Committee
Verrica Pharmaceuticals Inc. $104,310
Martine Zimmermann Joined Sep 8, 2026
- - Independent - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support